Compounds > azoxymethane
Page last updated: 2024-08-23

azoxymethane and Compensatory Hyperinsulinemia

azoxymethane has been researched along with Compensatory Hyperinsulinemia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hara, A; Hata, K; Hirose, Y; Kubota, M; Kuno, T; Moriwaki, H; Shimizu, M; Tanaka, T1
Camargo, JA; Carvalheira, JBC; Carvalho, HF; Damas-Souza, DM; de Carvalho, RB; Dias, MM; Flores, MBS; Osório-Costa, F; Rocha, GZ; Ropelle, ER; Saad, MJA1
Bruce, WR; Chia, MC; Giacca, A; Goh, T; Gupta, N; Koohestani, N; McKeown-Eyssen, G; Mehrotra, S; Naigamwalla, D; Tran, TT1
Hata, K; Hirose, Y; Kuno, T; Mori, H; Reddy, BS; Sakata, K; Tanaka, T; Yamada, Y; Yoshida, K1
Belalcazar, LM; Cowey, SL; Deng, X; Given, R; Quast, M; Singh, P; Wei, J1

Other Studies

5 other study(ies) available for azoxymethane and Compensatory Hyperinsulinemia

ArticleYear
Monosodium glutamate-induced diabetic mice are susceptible to azoxymethane-induced colon tumorigenesis.
    Carcinogenesis, 2012, Volume: 33, Issue:3

    Topics: Animals; Azoxymethane; Colonic Neoplasms; Diabetes Mellitus, Experimental; Disease Models, Animal; Disease Susceptibility; Hypercholesterolemia; Hyperglycemia; Hyperinsulinism; Insulin-Like Growth Factor I; Male; Mice; Mice, Inbred ICR; Precancerous Conditions; Receptor, IGF Type 1; RNA, Messenger; Sodium Glutamate

2012
RETRACTED: Obesity-induced increase in tumor necrosis factor-α leads to development of colon cancer in mice.
    Gastroenterology, 2012, Volume: 143, Issue:3

    Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Azoxymethane; Blotting, Western; Cell Proliferation; Colitis; Colon; Colonic Neoplasms; Dextran Sulfate; Disease Models, Animal; Enzyme Activation; HT29 Cells; Humans; Hyperinsulinism; Hypoglycemic Agents; I-kappa B Kinase; Immunohistochemistry; Inflammation Mediators; Infliximab; Insulin; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Inbred C57BL; Mice, SCID; Obesity; Phosphatidylinositol 3-Kinase; Pioglitazone; Proto-Oncogene Proteins c-akt; Signal Transduction; Thiazolidinediones; Time Factors; TOR Serine-Threonine Kinases; Tumor Burden; Tumor Necrosis Factor-alpha; Up-Regulation; Xenograft Model Antitumor Assays

2012
Direct measure of insulin sensitivity with the hyperinsulinemic-euglycemic clamp and surrogate measures of insulin sensitivity with the oral glucose tolerance test: correlations with aberrant crypt foci promotion in rats.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2003, Volume: 12, Issue:1

    Topics: Animals; Azoxymethane; Colorectal Neoplasms; Dietary Fats; Glucose Clamp Technique; Glucose Tolerance Test; Hyperinsulinism; Insulin; Insulin Resistance; Male; Precancerous Conditions; Rats; Rats, Inbred F344

2003
Enhancement of development of azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice.
    Carcinogenesis, 2004, Volume: 25, Issue:5

    Topics: Animals; Azoxymethane; Blood Glucose; Body Weight; Carcinogens; Colonic Neoplasms; Diabetes Mellitus, Experimental; Heterozygote; Homozygote; Hyperinsulinism; Immunoblotting; Insulin; Leptin; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Precancerous Conditions; Receptor, IGF Type 1; Receptors, Cell Surface; Receptors, Leptin

2004
Abdominal obesity, insulin resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression.
    Cancer, 2005, Jun-15, Volume: 103, Issue:12

    Topics: Animals; Azoxymethane; Body Weight; Carcinogens; Colonic Neoplasms; Gastrins; Gene Expression; Ghrelin; Glucose; Hyperinsulinism; Insulin; Insulin Resistance; Leptin; Magnetic Resonance Imaging; Male; Mice; Mice, Knockout; Obesity; Peptide Hormones; Precancerous Conditions; Radioimmunoassay; Thinness

2005